Monadic panmentalism, the hard problem of consciousness, and the ingredient problem
Synthese · 10.07.2026 · 208 (1)
DOI: 10.1007/s11229-026-05697-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthese, online erschienen am 10.07.2026. Verfasst von Savvas Ioannou. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Cyprus.
Abstract (Originalsprache)
The hard problem of consciousness, introduced by Chalmers (1995, 2017), reveals that merely dispositional and relational physical properties cannot ground phenomenal properties. Panpsychism attempts to address this problem by positing that micro-objects possess phenomenal properties that ground our phenomenal properties. However, Nagasawa (2021) has argued that panpsychism faces the ingredient problem: we lack a transparent grasp of microphenomenal properties, and as a result, we cannot explain how these microphenomenal properties ground our phenomenal properties. I will argue that a new metaphysical theory about the mind, panmentalism, can solve the hard problem of consciousness and the ingredient problem. This view holds that each micro-object possesses an ability to be conscious. Abilities to be conscious and physical properties produce phenomenal properties. Concerns about unmanifestable dispositions lead to the view that only simples possess the ability to be conscious and phenomenal properties.
Förderung
- University of Cyprus
Zitieren
APA
Ioannou, S. (2026). Monadic panmentalism, the hard problem of consciousness, and the ingredient problem. Synthese, 208(1). https://doi.org/10.1007/s11229-026-05697-5
Vancouver
Ioannou S. Monadic panmentalism, the hard problem of consciousness, and the ingredient problem. Synthese. 2026;208(1). doi:10.1007/s11229-026-05697-5
BibTeX
@article{Ioannou2026,
author = {Ioannou, Savvas},
title = {Monadic panmentalism, the hard problem of consciousness, and the ingredient problem},
journal = {Synthese},
year = {2026},
volume = {208},
number = {1},
doi = {10.1007/s11229-026-05697-5}
}
EUVIMED